Next Article in Journal
Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
Previous Article in Journal
Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia
Previous Article in Special Issue
Effectiveness of the BNT162b2 mRNA Vaccine Compared with Hybrid Immunity in Populations Prioritized and Non-Prioritized for COVID-19 Vaccination in 2021–2022: A Naturalistic Case-Control Study in Sweden
 
 
Review

Article Versions Notes

Vaccines 2022, 10(12), 2145; https://doi.org/10.3390/vaccines10122145
Action Date Notes Link
article xml file uploaded 14 December 2022 12:17 CET Original file -
article xml uploaded. 14 December 2022 12:17 CET Update https://www.mdpi.com/2076-393X/10/12/2145/xml
article pdf uploaded. 14 December 2022 12:17 CET Version of Record https://www.mdpi.com/2076-393X/10/12/2145/pdf
article html file updated 14 December 2022 12:18 CET Original file -
article html file updated 1 March 2023 04:11 CET Update -
article html file updated 4 March 2023 21:37 CET Update https://www.mdpi.com/2076-393X/10/12/2145/html
Back to TopTop